Serum-Soluble St2 As A Novel Biomarker Reflecting Inflammatory Status and Illness Severity in Patients with Covid-19
Authors:
- 18 December 2020
- journal article
- research article
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 14 (17) , 1619-1629
Abstract
Aim: The authors studied the role of soluble ST2 (sST2) in COVID-19 and its relationship with inflammatory status and disease severity. Materials & methods: Serum levels of sST2 and interleukin (IL...Keywords
Funding Information
- National Natural Science Foundation of China (81501033)
This publication has 37 references indexed in Scilit:
- Crucial and Diverse Role of the Interleukin-33/ST2 Axis in Infectious DiseasesInfection and Immunity, 2015
- IL‐33 Receptor (ST2) Signalling is Important for Regulation of Th2‐Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus InfectionScandinavian Journal of Immunology, 2015
- IL-33–Dependent Type 2 Inflammation during Rhinovirus-induced Asthma Exacerbations In VivoAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Infection with Influenza Virus Induces IL-33 in Murine LungsAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- High Levels of Soluble ST2 and Low Levels of IL-33 in Sera of Patients with HIV InfectionJournal of Investigative Dermatology, 2011
- The interleukin‐1 receptor/Toll‐like receptor superfamily: 10 years of progressImmunological Reviews, 2008
- Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway InflammationJournal of Biological Chemistry, 2007
- IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated CytokinesImmunity, 2005
- Protein Chip Array Profiling Analysis in Patients with Severe Acute Respiratory Syndrome Identified Serum Amyloid A Protein as a Biomarker Potentially Useful in Monitoring the Extent of PneumoniaClinical Chemistry, 2004
- Expression of Lymphocytes and Lymphocyte Subsets in Patients with Severe Acute Respiratory SyndromeClinical Infectious Diseases, 2003